| pubmed-article:18475377 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18475377 | lifeskim:mentions | umls-concept:C0003232 | lld:lifeskim |
| pubmed-article:18475377 | lifeskim:mentions | umls-concept:C0007876 | lld:lifeskim |
| pubmed-article:18475377 | lifeskim:mentions | umls-concept:C0677582 | lld:lifeskim |
| pubmed-article:18475377 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
| pubmed-article:18475377 | lifeskim:mentions | umls-concept:C0018517 | lld:lifeskim |
| pubmed-article:18475377 | lifeskim:mentions | umls-concept:C0445202 | lld:lifeskim |
| pubmed-article:18475377 | lifeskim:mentions | umls-concept:C0355642 | lld:lifeskim |
| pubmed-article:18475377 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:18475377 | pubmed:dateCreated | 2008-5-13 | lld:pubmed |
| pubmed-article:18475377 | pubmed:abstractText | Numerous studies demonstrate the efficacy of antibiotic prophylaxis for reducing postcesarean section infectious morbidity. The duration of therapy, however, remains controversial. Cost containment measures and the ease of single dosing have led to the introduction of "extended" half-life agents for cesarean-section chemoprophylaxis. We tested the hypothesis that there was no difference in efficacy between a single dose of a short half-life agent (cefoxitin) and a longer half-life agent (cefotetan). | lld:pubmed |
| pubmed-article:18475377 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18475377 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18475377 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18475377 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18475377 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18475377 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18475377 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18475377 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18475377 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18475377 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18475377 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18475377 | pubmed:status | PubMed-not-MEDLINE | lld:pubmed |
| pubmed-article:18475377 | pubmed:issn | 1064-7449 | lld:pubmed |
| pubmed-article:18475377 | pubmed:author | pubmed-author:GoninAA | lld:pubmed |
| pubmed-article:18475377 | pubmed:author | pubmed-author:McGregorJJ | lld:pubmed |
| pubmed-article:18475377 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:18475377 | pubmed:volume | 2 | lld:pubmed |
| pubmed-article:18475377 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18475377 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18475377 | pubmed:pagination | 120-5 | lld:pubmed |
| pubmed-article:18475377 | pubmed:year | 1994 | lld:pubmed |
| pubmed-article:18475377 | pubmed:articleTitle | Comparison of short vs. Long half-life single-dose prophylactic antibiotics for cesarean section. | lld:pubmed |
| pubmed-article:18475377 | pubmed:affiliation | Department of Obstetrics and Gynecology, University of Texas Medical School Houston, Houston, TX, USA. | lld:pubmed |
| pubmed-article:18475377 | pubmed:publicationType | Journal Article | lld:pubmed |
